AZTA: Azenta EV/EBITDA Multiple

Corporate emblem and logo of Azenta (AZTA)

Azenta, Inc. (AZTA) ensures the secure storage of biomaterials, fostering long-term customer loyalty due to the inherent risks associated with cell transportation. Excess liquidity and equipment supplies generate a reliable cash flow. An infrastructure ecosystem featuring robotics and software increases switching costs for laboratories moving to competitors. The business's current EV/EBITDA multiple reflects asset value dynamics, and this metric has settled at 38.01.

Brooks Automation - AZTA Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/10/2026)

Summary analytical data breakdowns for azenta.com (AZTA)

- stock price and consensus target price:
Stock Quotes Azenta Life Sciences|AZTA - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Brooks Automation|AZTA - Company Buyout Price
- issuer book value statistics:
Book Value per Share Azenta|AZTA - Company Net Assets|Market Cap to Net Assets Ratio azenta.com|AZTA - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Azenta, Inc.|AZTA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Azenta|AZTA - Company Cumulative Debt|Debts to Book Capitalization Brooks Automation|AZTA - Company Long-Term Indebtedness|Company Short-Term Debts Azenta|Quick Ratio azenta.com
- financial results and valuation multiples details:
AZTA - Net Income|Projected Future Earnings Azenta, Inc.|AZTA - P/E Multiple|Future Price to Earnings Azenta, Inc.|AZTA - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Brooks Automation|AZTA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Azenta|AZTA - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months azenta.com|AZTA - Net earnings per share change in current year|Expected earnings per share growth for next year Azenta, Inc.
Initial company analysis:Azenta Life Sciences AZTA
Original product of azenta.com

The multiple combines market capitalization and net debt, dividing them by operating profit before depreciation and amortization to determine the real value of the business. By analyzing the EV/EBITDA value of Azenta, Inc. (AZTA) on the chart, an investor assesses the return on assets for Azenta, Inc., where the optimization of cryogenic equipment logistics directly impacts cash flow efficiency and the issuer's final market value.

Competitor analysis for Azenta, Inc.

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|VREX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Semler Scientific, Inc. (SMLR)|Enterprise Value to EBITDA Ratio butterflynetwork.com BFLY|EV/EBITDA Multiple MLAB (Mesa Labs)|Quantum-Si Inc. (QSI) - Company Value to EBITDA|Nanox - EV/EBITDA Multiple|QTRX (Quanterix Inc) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)